×î×¼µÄÁùºÏ²ÊÂÛ̳

XClose

Joint Research Office

Home
Menu

Latest JRO guidance on Brexit issued

14 October 2020

The JRO has updated its guidance and FAQs on Brexit, as the UK approaches the end of the transition period which ends in December 2020.

In the event that the UK and EU do not reach an agreement on a deal, there will be implications for research studies – both sponsored by ×î×¼µÄÁùºÏ²ÊÂÛ̳ or ×î×¼µÄÁùºÏ²ÊÂÛ̳H or hosted by ×î×¼µÄÁùºÏ²ÊÂÛ̳H.

We have developed the following documents:

  • Guidance setting out actions to be taken by ×î×¼µÄÁùºÏ²ÊÂÛ̳ and ×î×¼µÄÁùºÏ²ÊÂÛ̳H investigators to prepare for the event of ‘no deal’ at the end of the transition period.
  • FAQs for researchers on planning for a possible ‘no deal’.
  • JRO Brexit position statement on ×î×¼µÄÁùºÏ²ÊÂÛ̳ clinical trials portfolio.

Researchers who have questions are advised to contact: uclh.jro-communications@nhs.net.